Whalen Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$370K Sell
738
-642
-47% -$308K 0.17% 144
2026
Q1
$678K Sell
1,380
-1,343
-49% -$729K 0.36% 75
2025
Q4
$1.58M Sell
2,723
-666
-20% -$377K 0.85% 23
2025
Q3
$1.64M Buy
3,389
+2,469
+268% +$1.15M 0.96% 24
2025
Q2
$373K Buy
+920
New +$385K 0.23% 121

Other funds holding TMO

Whalen Wealth Management's TMO Position: Q2 2026 in Review

Whalen Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 47% in Q2 2026, selling an estimated $308K and leaving 738 shares worth $370K. The position accounts for 0.17% of the portfolio, ranked #144.

Whalen Wealth Management first reported a position in TMO in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.64M in Q3 2025. 2,623 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Whalen Wealth Management held 738 shares of Thermo Fisher Scientific worth $370K as of Q2 2026.
  • Whalen Wealth Management sold 642 Thermo Fisher Scientific shares in Q2 2026, an estimated $308K.
  • Thermo Fisher Scientific made up 0.17% of Whalen Wealth Management's portfolio in Q2 2026, its #144 holding.
  • Whalen Wealth Management first reported a position in Thermo Fisher Scientific in Q2 2025 and has held it in 5 quarters since.
  • Whalen Wealth Management's Thermo Fisher Scientific position peaked at $1.64M in Q3 2025.
  • 2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Whalen Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.